This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1991 Apr;54(4):376-7.

doi: 10.1136/jnnp.54.4.376-a.

Buspirone in the treatment of levodopa induced dyskinesias

B Kleedorfer, A J Lees, G M Stern

PMID: 2056334
PMCID: PMC488507
DOI: 10.1136/jnnp.54.4.376-a

Buspirone in the treatment of levodopa induced dyskinesias

B Kleedorfer et al. J Neurol Neurosurg Psychiatry. 1991 Apr.

. 1991 Apr;54(4):376-7.

doi: 10.1136/jnnp.54.4.376-a.

Authors

B Kleedorfer, A J Lees, G M Stern

PMID: 2056334
PMCID: PMC488507
DOI: 10.1136/jnnp.54.4.376-a

No abstract available

PubMed Disclaimer

Similar articles

Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease.
Colzi A, Turner K, Lees AJ. Colzi A, et al. J Neurol Neurosurg Psychiatry. 1998 May;64(5):573-6. doi: 10.1136/jnnp.64.5.573. J Neurol Neurosurg Psychiatry. 1998. PMID: 9598668 Free PMC article.
Buspirone in levodopa-induced dyskinesias.
Bonifati V, Fabrizio E, Cipriani R, Vanacore N, Meco G. Bonifati V, et al. Clin Neuropharmacol. 1994 Feb;17(1):73-82. doi: 10.1097/00002826-199402000-00008. Clin Neuropharmacol. 1994. PMID: 8149361 Clinical Trial.
High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias.
Facca A, Sanchez-Ramos J. Facca A, et al. Mov Disord. 1996 May;11(3):327-9. doi: 10.1002/mds.870110319. Mov Disord. 1996. PMID: 8723153 No abstract available.
Rating scales for dyskinesias in Parkinson's disease.
Goetz CG. Goetz CG. Mov Disord. 1999;14 Suppl 1:48-53. Mov Disord. 1999. PMID: 10493403 Review. No abstract available.
[Medical treatment of L-dopa induced dyskinesia].
Kuno S. Kuno S. Nihon Rinsho. 2000 Oct;58(10):2110-4. Nihon Rinsho. 2000. PMID: 11068456 Review. Japanese. No abstract available.

See all similar articles

Cited by

Methods of managing levodopa-induced dyskinesias.
Giron LT Jr, Koller WC. Giron LT Jr, et al. Drug Saf. 1996 Jun;14(6):365-74. doi: 10.2165/00002018-199614060-00002. Drug Saf. 1996. PMID: 8828014 Review.
Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients.
Politis M, Wu K, Loane C, Brooks DJ, Kiferle L, Turkheimer FE, Bain P, Molloy S, Piccini P. Politis M, et al. J Clin Invest. 2014 Mar;124(3):1340-9. doi: 10.1172/JCI71640. Epub 2014 Feb 17. J Clin Invest. 2014. PMID: 24531549 Free PMC article. Clinical Trial.
Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study.
Svenningsson P, Rosenblad C, Af Edholm Arvidsson K, Wictorin K, Keywood C, Shankar B, Lowe DA, Björklund A, Widner H. Svenningsson P, et al. Brain. 2015 Apr;138(Pt 4):963-73. doi: 10.1093/brain/awu409. Epub 2015 Feb 10. Brain. 2015. PMID: 25669730 Free PMC article. Clinical Trial.
Drug-induced movement disorders.
Jiménez-Jiménez FJ, García-Ruiz PJ, Molina JA. Jiménez-Jiménez FJ, et al. Drug Saf. 1997 Mar;16(3):180-204. doi: 10.2165/00002018-199716030-00004. Drug Saf. 1997. PMID: 9098656 Review.
Non-dopamine receptor ligands for the treatment of Parkinson's disease. Insight into the related chemical/property space.
Ivanenkov YA, Veselov MS, Chufarova NV, Majouga AG, Kudryavceva AA, Ivachtchenko AV. Ivanenkov YA, et al. Mol Divers. 2016 Feb;20(1):345-65. doi: 10.1007/s11030-015-9598-y. Epub 2015 May 9. Mol Divers. 2016. PMID: 25956815 Review.

See all "Cited by" articles

References

1. J Neurol Neurosurg Psychiatry. 1975 Apr;38(4):331-5 - PubMed
1. J Neurol Neurosurg Psychiatry. 1990 Feb;53(2):93-5 - PubMed
1. J Clin Psychiatry. 1982 Dec;43(12 Pt 2):4-10 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information